The Termeer Foundation
Jim Geraghty serves as the Chairman of OMass Therapeutics since May 2023 and holds multiple board chair positions at Orchard Therapeutics and Pieris Pharmaceuticals, alongside a directorship at Fulcrum Therapeutics and Voyager Therapeutics, Inc. Previously, Jim Geraghty was an Entrepreneur in Residence at Third Rock Ventures and held senior leadership roles at sanofi-aventis and Genzyme. Educationally, Jim Geraghty earned a Doctor of Law (J.D.) from Yale Law School, a Master of Science (MS) in Psychology from the University of Pennsylvania, and a Bachelor of Arts (B.A.) in English Literature from Georgetown University.
This person is not in the org chart
The Termeer Foundation
Building on the bold legacy of Henri Termeer, who pioneered groundbreaking treatments for rare diseases, The Termeer Foundation is a nonprofit organization focused on connecting life science innovators and catalyzing the creation of new medicines.